NGeneBio Co., Ltd.
Provides NGS-based diagnostics, software, and liquid biopsy for precision oncology and healthcare.
354200 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 구로구 디지털로 288 303호. 304호. 305호. 306호. 307호. 제지1층 제비 127호, 제지1층 제비 1, 구로구
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
NGeneBio Co., Ltd. is a biotechnology company specializing in molecular diagnostics (MDx) and companion diagnostics (CDx) based on Next-Generation Sequencing (NGS) technology. The company develops and provides precision diagnostic solutions, including NGS-based panels for oncology (e.g., breast and ovarian cancer), bioinformatics analysis software, and liquid biopsy products. NGeneBio also offers personalized genetic-based healthcare services. As a leading supplier to hospitals in its domestic market, the company is focused on expanding its presence in the global precision medicine field.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for NGeneBio Co., Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all NGeneBio Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for NGeneBio Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
